Gilead Sciences
GILD
#140
Rank
$153.65 B
Marketcap
$123.76
Share price
-1.35%
Change (1 day)
14.06%
Change (1 year)

Gilead Sciences (GILD) - Cash on Hand

Cash on Hand as of March 2026 : $7.64 Billion USD

According to Gilead Sciences's latest financial reports the company has $7.64 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Gilead Sciences - Cash on Hand chart (from 1996 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31$9.61 B-16.9%
2024-12-31$11.56 B59.25%
2023-12-31$7.26 B13.77%
2022-12-31$6.38 B-2.07%
2021-12-31$6.52 B-11.99%
2020-12-31$7.40 B-69.58%
2019-12-31$24.35 B-19.07%
2018-12-31$30.08 B17.95%
2017-12-31$25.51 B114.46%
2016-12-31$11.89 B-18.57%
2015-12-31$14.60 B44.22%
2014-12-31$10.12 B375.05%
2013-12-31$2.13 B14.49%
2012-12-31$1.86 B-81.19%
2011-12-31$9.90 B371.74%
2010-12-31$2.09 B26.66%
2009-12-31$1.65 B-7.43%
2008-12-31$1.79 B52.74%
2007-12-31$1.17 B25.1%
2006-12-31$0.93 B-59.46%
2005-12-31$2.31 B84.29%
2004-12-31$1.25 B77.37%
2003-12-31$0.70 B-24.98%
2002-12-31$0.94 B61.68%
2001-12-31$0.58 B13.64%
2000-12-31$0.51 B74.21%
1999-12-31$0.29 B191.19%
1998-12-31$0.10 B215.94%
1997-12-31$32 M-75.76%
1996-12-31$0.13 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
$22.05 B 188.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$13.07 B 71.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$9.39 B 22.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$5.28 B-30.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$12.03 B 57.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$4.28 B-43.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
$1.15 B-84.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
$7.24 B-5.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$5.70 B-25.40%๐Ÿ‡บ๐Ÿ‡ธ USA